Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.06.12.731946

Molecular interplay between Integrative Mobile Elements exploiting Xer drives the evolution of cholera pandemics

Abstract

XerC and XerD are ubiquitous bacterial recombinases dedicated to chromosome dimer resolution. They add a crossover at a specific chromosomal site, dif, when activated by the FtsK cell division protein. Several integrative mobile elements exploiting Xer (IMEXs) have been reported. IMEXs hijack XerCD to integrate at dif in an FtsK-independent manner. The most notable IMEX is the CTX{Phi} bacteriophage of Vibrio cholerae, which encodes the Cholera toxin. V. cholerae isolates often contain several sequentially integrated IMEX, forming arrays. In the current cholera pandemic lineage, CTX{Phi} integrated in the dif site of the primary V. cholerae chromosome, difI, after the integration of another IMEX, TLC{Phi} (Toxin-Linked Cryptic). The strict order of TLC{Phi} and CTX{Phi} integration has been explained via a dif site-correction hypothesis, where the difI site of the environmental ancestor of the current pandemic isolates was non-functional and was corrected by the integration of TLC{Phi}. Here, we traced the inheritance of difI variants and IMEXs in environmental and pandemic isolates. We show that IMEX arrays undergo rearrangements not congruent with the core genome phylogeny and that TLC{Phi} integration preceded CTX{Phi} integration in pandemic lineages. We demonstrate that the difI sites of environmental and pandemic isolates are equally functional for dimer resolution and CTX{Phi} integration, and show that TLC{Phi} and another IMEX, VGJ{Phi}, encode a Xer activation factor that facilitates CTX{Phi} integration, suggesting an alternate explanation for the integration order of IMEX in environmental and pandemic isolates. Significance statementCholera is an increasing threat due to climate change. Vibrio cholerae pandemic potential is intricately linked to its infection by a lysogenic phage, the CTX{Phi}, which encodes the Cholera Toxin. CTX{Phi} uses the Xer recombination of its host for genomic integration. We established that CTX{Phi} is integrated downstream of the TLC{Phi} phage satellite in pandemic lineages and that it is frequently integrated downstream of the VGJ{Phi} phage in environmental strains. Our results show that TLC{Phi} and VGJ{Phi} encode for distinct Xer activator proteins (Xafs) that facilitate CTX{Phi} integration, providing a mechanistic explanation for the observed integration order. This novel molecular interplay is crucial to understanding the development of pandemic V. cholerae, with a view to preventing future expansions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Moranchel, O., Balanec, M., Verron, B., Royer, L., POSSOZ, C., Guerrois, R., VERGNAUD, G., WEILL, F.-X., PROVAN, J., Barre, F.-X.. 2026-06-13. Molecular interplay between Integrative Mobile Elements exploiting Xer drives the evolution of cholera pandemics. https://doi.org/10.64898/2026.06.12.731946

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗